New York, NY, September 13, 2018 --(PR.com
)-- New research just published in Integrative Cancer Therapies shows that the Pao pereira plant extract inhibits pancreatic cancer stem cells. This dramatic result means that the extract will be useful for preventing cancer recurrence.
Everyone knows that cancer treatments are not cancer cures. Chemotherapy treatments kill cancer cells and shrink tumors, but the cancer often comes back. Cancer stem cells (CSCs) are the culprit because they are resistant to anti-cancer drugs, they can metastasize and form new tumors. CSCs make up a small fraction of the cells in a tumor that survive after the majority of primary cancer cells are killed by anti-cancer drugs. The CSCs persist, spread and restart tumor growth.
CSCs are also referred to as cancer stem-like cells because they share the capacity for self-proliferation with normal stem cells that are involved in the renewal and repair of tissues, but unlike normal stem cells CSCs are cancerous and drug resistant.
In cell-based studies the Pao pereira extract significantly reduced the pancreatic cancer stem cell population. In vivo experiments showed that Pao pereira inhibited the capacity of pancreatic CSCs to form tumors—the defining characteristic of CSCs. Pao works by lowering the signals that trigger the pancreatic cancer stem-like cell properties that lead to cancer recurrence.
The researchers at Kansas University Medical Center concluded that Pao pereira holds great promise as a novel treatment for targeting pancreatic CSCs, an essential component of treatments that will lead to real cancer cures.
This research was sponsored by The Beljanski Foundation, a 501(c)(3) non-profit organization to help fund anti-cancer research to cure cancer the natural way. For more information please visit https://www.beljanski.org/ or email firstname.lastname@example.org.
Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo.
R. Dong, P. Chen and Q Chen. Integrative Cancer Therapies. July 2018.